Table 2.
Description of overall cohort (n = 101)
| Variables | Frequency n (%) |
|---|---|
| Mean age (years) | 53.5 (95% CI 50.4–56.6) |
| Male | 64 (63.4) |
| Race | |
| Chinese | 43 (42.6) |
| Malay | 39 (38.6) |
| Indian | 15 (14.9) |
| Others | 4 (4.0) |
| Past history | |
| Hyperlipidemia | 48 (47.5) |
| Hypertension | 53 (52.9) |
| Ischemic Heart Disease | 8 (7.9) |
| Stroke | 4 (4.0) |
| Acute Myocardial Infarction | 3 (3.0) |
| Duration of DM | |
| New presentation | 27 (26.7) |
| Less than 6 months | 9 (8.9) |
| 6 months to 1 year | 7 (6.9) |
| 1 to 5 years | 17 (16.8) |
| 5 to 10 years | 21 (20.8) |
| 10 years and above | 20 (19.8) |
| Current medications for known diabetics (n = 74) | |
| Diet control only | 1 (1.4) |
| OHA only | 36 (48.6) |
| Insulin only | 12 (16.2) |
| OHA + insulin | 25 (33.7) |
| Mean HbA1C (%) (n = 85) | 12.8 (95% CI 12.3–13.3) |
| Mean glucose (mmols/L) | |
| Admission | 27.2 (95% CI 26.3–28.1) |
| Discharge | 13.9 (95% CI 13.2–14.6) |
| OU outcomes | |
| Discharged | 91 (90.1) |
| Admitted to the ward | 10 (9.9) |
OU observation unit, OHA oral hypoglycaemic agent